Sanofi India Chief Departs, Sets Transformative Path
Outgoing Exec To Lead SeQuent Scientific
Executive Summary
Sanofi India's managing director is moving on after an eventful innings that saw the company re-orient operations, moving out of certain non-strategic areas to focus on core therapies. Pre-pandemic early digital adoption appears to have played out well too for the French group’s listed Indian arm.
You may also be interested in...
CEO Pay Mostly Up In India In Year Of C-Suite Exits
Most CEOs/MDs at leading listed foreign and domestic drug firms in India took home bigger pay packages in 2021-22, a period that also saw several top-level exits including at Abbott, Pfizer and Sanofi. Scrip examines some of the wider trends around executive compensation.
Sanofi India Offloads Nutraceuticals Business To Local Player
Sanofi India – in which France’s Sanofi S.A. holds a controlling 60% stake – is to divest its Nutraceuticals business in a deal worth around $80m.
Zentiva Opens India Office As It Completes Ankleshwar Plant Deal
Zentiva is opening a dedicated Indian office in Mumbai to support the Ankleshwar manufacturing facility that it has just acquired from former parent company Sanofi.